[0075] The present disclosure relates to the use of intranasal neuropeptide Y (NPY) analogs having D-amino acids, such as [D26-His]-NPY: (1) for early intervention to prevent or (2) to treat, to reverse, or reduce symptoms of stress-related impairments such as PTSD, depression, substance abuse, and/or memory deficits following exposure to traumatic or surgical stress.
INTRANASAL NEUROPEPTIDES FOR USE IN STRESS-RELATED IMPAIRMENTS